[HTML][HTML] Folate receptor as a biomarker and therapeutic target in solid tumors

O Young, N Ngo, L Lin, L Stanbery, JF Creeden… - Current Problems in …, 2023 - Elsevier
Folate is a B vitamin necessary for basic biological functions, including rapid cell turnover
occurring in cancer cell proliferation. Though the role of folate as a causative versus …

[PDF][PDF] Management of cytotoxic chemotherapy-induced hand-foot syndrome

JJM Kwakman, YS Elshot, CJA Punt… - Oncology …, 2020 - frontierspartnerships.org
Improvements in systemic cancer treatments have resulted in more patients surviving for
prolonged periods of time on treatment. This has made treatment-related toxicity and quality …

Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy

T Lang, R Zhu, X Zhu, W Yan, Y Li, Y Zhai, T Wu… - Nature …, 2023 - nature.com
Colorectal cancer (CRC) therapy efficiency can be influenced by the microbiota in the
gastrointestinal tract. Compared with traditional intervention, prebiotics delivery into the gut …

[HTML][HTML] Chronic kidney disease as a global public health problem: approaches and initiatives–a position statement from Kidney Disease Improving Global Outcomes

AS Levey, R Atkins, J Coresh, EP Cohen, AJ Collins… - Kidney international, 2007 - Elsevier
Chronic kidney disease (CKD) is increasingly recognized as a global public health problem.
There is now convincing evidence that CKD can be detected using simple laboratory tests …

Cetuximab for the treatment of colorectal cancer

DJ Jonker, CJ O'Callaghan, CS Karapetis… - … England Journal of …, 2007 - Mass Medical Soc
Background Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth
factor receptor (EGFR), has activity against colorectal cancers that express EGFR. Methods …

Capecitabine as adjuvant treatment for stage III colon cancer

C Twelves, A Wong, MP Nowacki, M Abt… - … England Journal of …, 2005 - Mass Medical Soc
Background Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant
treatment for colon cancer. The oral fluoropyrimidine capecitabine is an established …

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

D Cunningham, I Chau, DD Stocken… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Both gemcitabine (GEM) and fluoropyrimidines are valuable treatment for
advanced pancreatic cancer. This open-label study was designed to compare the overall …

Capecitabine: a review

CM Walko, C Lindley - Clinical therapeutics, 2005 - Elsevier
BACKGROUND:: Fluorouracil (FU) is an antimetabolite with activity against numerous types
of neoplasms, including those of the breast, esophagus, larynx, and gastrointestinal and …

Colon cancer

R Labianca, GD Beretta, B Kildani, L Milesi… - Critical reviews in …, 2010 - Elsevier
Colon cancer is one of the leading tumours in the world and it is considered among the big
killers, together with lung, prostate and breast cancer. In the recent years very important …

Interventions for preventing oral mucositis for patients with cancer receiving treatment

HV Worthington, JE Clarkson, G Bryan… - Cochrane database …, 2011 - cochranelibrary.com
Background Treatment of cancer is increasingly more effective but is associated with short
and long term side effects. Oral side effects remain a major source of illness despite the use …